Yumiko Kutoku

Modeling Alzheimer’s Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular Aβ and Differential Drug Responsiveness

Takayuki Kondo, Masashi Asai, Kayoko Tsukita et al. · Cell stem cell · 2013 · 752 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons

Keiko Imamura, Naruhiko Sahara, Nicholas M. Kanaan et al. · Scientific Reports · 2016 · 82 citations · Full text

Medicine, Neurology, Neuroscience +17

Clinical Benefits of Antioxidative Supplement Twendee X for Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Prospective Interventional Study

Koh Tadokoro, Ryuta Morihara, Yasuyuki Ohta et al. · Journal of Alzheimer s Disease · 2019 · 37 citations

Medicine, Neurology, Neuroscience +17

Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations

Takayuki Kondo, Haruhiko Banno, Taro Okunomiya et al. · BMJ Open · 2021 · 27 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A simplified and sensitive method to identify Alzheimer’s disease biomarker candidates using patient-derived induced pluripotent stem cells (iPSCs)

Keiro Shirotani, Kazuya Matsuo, Sumio Ohtsuki et al. · The Journal of Biochemistry · 2017 · 20 citations

Life Sciences, Neurobiology, Neuroscience +17